Cabot (NYSE:CBT) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Cabot (NYSE:CBTGet Free Report) released its quarterly earnings results on Monday. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01), Briefing.com reports. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. Cabot’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.65 earnings per share. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Price Performance

Shares of NYSE CBT traded up $8.16 during trading on Wednesday, reaching $117.02. The company had a trading volume of 765,067 shares, compared to its average volume of 339,948. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. The stock has a market cap of $6.42 billion, a PE ratio of 17.36, a PEG ratio of 0.91 and a beta of 1.20. The business’s 50 day moving average price is $108.41 and its 200-day moving average price is $101.13. Cabot has a 52 week low of $68.11 and a 52 week high of $117.37.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. UBS Group reduced their price target on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Mizuho boosted their price target on shares of Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $105.00.

Check Out Our Latest Stock Report on CBT

Insider Buying and Selling

In related news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Erica Mclaughlin sold 16,390 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at approximately $6,235,011.36. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,665 shares of company stock valued at $4,986,299 over the last ninety days. Insiders own 3.07% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Read More

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.